BSE filing, BSE: 544805. Summary written from the filing by ALFA Finder's alert engine.
Jivial Industries Ltd: key numbers
- Share price
- ₹78.00
- Market cap
- ₹36.42 Cr
- Revenue (annual)
- ₹17.63 Cr
- Net profit (annual)
- ₹3.75 Cr
- P/E (TTM)
- 9.7×Sector 16.9×
- Promoter holding
- 61.17%
- FII holding
- 9.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jivial Industries Ltd
All →Jivial Industries Management Change
Jivial Industries' board accepted CFO Dhara Vekariya's resignation and appointed Mr. Shubham Sagpariya as the new CFO effective 22 Oct 2026. The board also approved a postal ballot to alter IPO objects.
Jivial Industries Annual General Meeting
Jivial Industries Ltd held its 5th Annual General Meeting on 30th September, 2026 via video conferencing. The meeting transacted ordinary business, including adoption of financial statements.
Jivial Industries Annual Report
Jivial Industries Limited has filed its Annual Report for the Financial Year 2025-26, which includes the Notice for its 5th Annual General Meeting.
Jivial Industries Annual General Meeting
Jivial Industries Ltd has announced the closure of its register of members from September 21 to September 30, 2026, for its 5th Annual General Meeting.
Jivial Industries Board Meeting Outcome
Jivial Industries held a board meeting on September 4, 2026, to approve the Director's Report and schedule the 5th Annual General Meeting.
Jivial Industries Management Change
Jivial Industries Limited appointed N. N. Kapuriya & Co as Internal Auditor and G R Shah and Associates as Secretarial Auditor for a 24-month term.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.